Aesculap US to distribute IsoTis bone matrix:
This article was originally published in Clinica
IsoTis OrthoBiologics has appointed Aesculap US as a non-exclusive distributor of its demineralised bone matrix product, DynaGraft II DBM. The Center Valley, Pennsylvania-based subsidiary of German multinational Aesculap is to market the product under the brand name ProSpace DBM through its direct sales force. With Aesculap's spinal franchise growing at over 30% per year, it is hoped the move will indirectly increase IsoTis's share of the US spinal surgery market, says the Lausanne, Switzerland-based firm.
You may also be interested in...
Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.
The reality is that many trials requiring hospital based tests and interventions cannot be replaced, but crisis will spur take up where practical.
The two companies announced more details about their COVID-19 vaccine development plan, including a $185m upfront payment and $113m equity investment from Pfizer.